𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-α

✍ Scribed by J.L. Steegmann; M.J. Requena; P. Martín-Regueira; R. de la Cámara; F. Casado; F. Rodriguez Salvanés; J.M. Fernández Rañada

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
104 KB
Volume
72
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe autoimmune hepatitis in a chronic
Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic response
✍ Steegmann, Juan Luis; Requena, María José; García-Buey, María Luisa; Granados, E 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB 👁 1 views

A patient with chronic myeloid leukemia (CML) treated with interferon alpha (IFN alpha) and who developed autoimmune hepatitis (AIH) is described. The patient was treated with IFN alpha 2a, a complete cytogenetic response was achieved 5 months later, and this response has lasted now more than 7 year

Cutaneous sarcoidosis in a patient with
Cutaneous sarcoidosis in a patient with philadelphia-positive chronic myelogenous leukemia treated with interferon-α
✍ Yavorkovsky, Leonid L.; Carrum, George; Bruce, Suzanne; McCarthy, Philip L. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 17 KB 👁 1 views

A patient with Philadelphia-positive (Ph+) chronic myelogenous leukemia (CML) was diagnosed with cutaneous sarcoidosis after treatment with interferon-alpha (IFN-␣). Following IFN-␣ dose reduction, the skin lesions disappeared. Few cases of sarcoidosis associated with IFN treatment have been reporte

Interferon-α-associated focal segmental
Interferon-α-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy
✍ Manisha Shah; Edwin H. Jenis; Basab K. Mookerjee; Jeffrey R. Schriber; Maria R. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## BACKGROUND. Acute renal failure, with or without massive proteinuria, is a rare idiosyncratic toxicity of interferon (IFN)-␣ therapy. The authors sought to review their experience with this toxicity as well as the world literature on the subject. ## METHODS. The authors describe two patients